What To Know About New FDA Informed Consent Guidance
On July 25, 2017, the U.S. Food and Drug Administration issued a guidance document[1] announcing its intention not to object to an institutional review board's (IRB) waiving or altering of the...To view the full article, register now.
Already a subscriber? Click here to view full article